Forbes – A major day of deal-making in the red hot biotech and pharmaceutical sector is paying for healthcare focused hedge fund Deerfield Management.
On Monday, two of the fund’s largest publicly traded positions, Auspex Pharmaceuticals and Horizon Pharma HZNP +22.14%, both announced billion dollar-plus deals, catapulting their shares to new record highs.
